Zai Lab Announces Potential Pricing for IPO
Biopharmaceutical company Zai Lab intends to price its 8 million shares in the range that results in an initial public offering valued up to more than $165 million.
All Work
Chris Lange
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a relatively flat day for the broad U.S. markets with two out of the three major averages hitting new all-time highs in the session. Crude oil was up on the day and…
Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock
Alnylam Pharmaceuticals saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis with polyneuropathy.
Best Enters the Market With a Bang
Chinese logistics firm Best entered the market with a bang on Wednesday, the largest IPO by a Chinese firm in the United States in almost a year.
Why Record Revenues Aren’t Enough for Adobe Investors
Adobe Systems released its most recent quarterly results after the markets closed on Tuesday and investors were not happy.
Is Bed Bath & Beyond Surrendering to the Amazon Effect?
Bed Bath & Beyond saw its shares fall on Wednesday after the company issued its most recent earnings report.
Why FedEx Is Taking a Step Back After Earnings
FedEx reported disappointing fiscal first-quarter earnings after the markets closed on Tuesday and lowered its guidance.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was another positive day for the U.S. broad markets with all three major averages hitting new all-time highs in the session. Crude oil was lower on the day and Oil & Gas stocks…
What to Expect When FedEx Reports After the Close
FedEx is scheduled to release its most recent quarterly results after the markets close on Tuesday.
Sprint and T-Mobile Reportedly in Active Merger Talks
Both Sprint and T-Mobile shares made handy gains on Tuesday after it came to light that these major telecom players were actively in merger talks.
MediWound Secondary Capitalizes on 2017 Success
Biotech companies may attempt a secondary offering after seeing a run in the share price. So now seems the as good a time as any for MediWound to capitalize in 2017.
Why Synchronoss Shares Are Getting Crushed
Synchronoss Technologies saw its shares take a big step back, almost touching a multiyear low, after the firm provided an update on its strategic alternatives.
Do AutoZone Q4 Earnings Mean It Is on the Right Track?
AutoZone reported better-than-expected fiscal fourth-quarter financial results before the markets opened on Tuesday.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a positive day for the U.S. broad markets with all three major averages touching a new all-time high in the session. Crude oil was flat on the day but overall Oil &…
Will Dimension Therapeutics Take the New and Bigger Buyout Offer?
Dimension Therapeutics saw one of the largest gains on the day after it came to light that the firm received an acquisition offering from Ultragenyx Pharmaceutical.
Can Earnings Get AutoZone Back on Track?
AutoZone shares have taken a beating in 2017 so far at the hands of weak earnings, industry sales trends, and the specter of Amazon.com.
Why Merrill Lynch Is Pushing Nvidia to All-Time Highs
Nvidia is now a staple in the tech industry after experiencing explosive growth in just the past couple of years, and it doesn’t look like shares will be slowing down any time soon.
Deciphera Pharma Takes Another Step Closer to IPO
Deciphera Pharmaceuticals expects to price more than 6 million shares in a range that results in an initial public offering valued up to more than $122 million.
Pluristem Wins Key FDA Approval
Shares of Pluristem Therapeutics saw a handy gain early Monday after the company said it had received a key update from the FDA.
Roku Announces Potential Pricing for IPO
Roku intends to price more than 15 million shares in a range that results in an initial public offering valued up to more than $252 million.